Cold & Cough Remedies - Mauritius

  • Mauritius
  • In Mauritius, the revenue in the Cold & Cough Remedies market market is recorded at US$6.20m in 2024.
  • Looking ahead, the market is projected to experience an annual growth rate of 6.84% (CAGR 2024-2029).
  • When comparing globally, it is worth noting that the in the United States generates the highest revenue in this market, reaching US$11,190.00m in 2024.
  • To put the revenue figures into perspective, in 2024, the per person revenue stands at US$4.76, taking into consideration the total population of Mauritius.
  • Mauritius has seen a growing demand for natural and herbal cold & cough remedies in the OTC Pharmaceuticals market.

Key regions: Australia, Japan, India, Brazil, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Mauritius is experiencing steady growth due to several factors.

Customer preferences:
Customers in Mauritius have shown a preference for over-the-counter cold and cough remedies that provide quick relief from symptoms. They are increasingly seeking products that are easy to use and do not require a prescription. This preference is driven by the busy lifestyles of consumers, who are looking for convenient solutions to alleviate their symptoms. Additionally, customers in Mauritius are becoming more health-conscious and are actively seeking products that are natural and have minimal side effects.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Mauritius is the increasing demand for herbal and natural remedies. Consumers are becoming more aware of the potential side effects of conventional medicines and are seeking alternative options. This trend is in line with the global shift towards natural and holistic healthcare solutions. As a result, there has been a rise in the availability of herbal and natural cold and cough remedies in the market.Another trend in the market is the growing popularity of combination remedies. Customers in Mauritius are looking for products that can address multiple symptoms at once. Combination remedies that offer relief from both cold and cough symptoms are gaining traction in the market. These products provide convenience to consumers by reducing the need to purchase multiple remedies for different symptoms.

Local special circumstances:
Mauritius has a tropical climate, which makes it prone to seasonal changes and fluctuations in temperature. These changes in weather often lead to an increase in the incidence of cold and cough among the population. As a result, the demand for cold and cough remedies tends to be higher during certain times of the year, such as the rainy season. Manufacturers and retailers in Mauritius need to be aware of these seasonal fluctuations and adjust their marketing and stocking strategies accordingly.

Underlying macroeconomic factors:
The steady growth of the Cold & Cough Remedies market in Mauritius can be attributed to several underlying macroeconomic factors. The country has been experiencing economic growth in recent years, which has led to an increase in disposable income among the population. As a result, consumers in Mauritius have more purchasing power and are able to afford healthcare products, including cold and cough remedies.Furthermore, the government of Mauritius has been investing in healthcare infrastructure and promoting awareness about the importance of preventive healthcare. This has led to an increase in healthcare expenditure and a greater focus on self-care among the population. As a result, consumers are more likely to purchase cold and cough remedies to manage their symptoms at home.In conclusion, the Cold & Cough Remedies market in Mauritius is growing steadily due to customer preferences for convenient and natural remedies, the trend towards combination remedies, the local special circumstances of seasonal fluctuations in cold and cough incidence, and the underlying macroeconomic factors of economic growth and increased healthcare expenditure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)